351 related articles for article (PubMed ID: 22142554)
1. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
Squires H; Simpson E; Meng Y; Harnan S; Stevens J; Wong R; Thomas S; Michaels J; Stansby G
Health Technol Assess; 2011 Dec; 15(40):1-210. PubMed ID: 22142554
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
Guest JF; Davie AM; Clegg JP
Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol for intermittent claudication.
Bedenis R; Stewart M; Cleanthis M; Robless P; Mikhailidis DP; Stansby G
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003748. PubMed ID: 25358850
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol for intermittent claudication.
Brown T; Forster RB; Cleanthis M; Mikhailidis DP; Stansby G; Stewart M
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003748. PubMed ID: 34192807
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline for intermittent claudication.
Broderick C; Forster R; Abdel-Hadi M; Salhiyyah K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD005262. PubMed ID: 33063850
[TBL] [Abstract][Full Text] [Related]
8. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
Hong H; Mackey WC
Clin Ther; 2014 Aug; 36(8):1290-301. PubMed ID: 25012728
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol for peripheral arterial disease.
Robless P; Mikhailidis DP; Stansby GP
Cochrane Database Syst Rev; 2008 Jan; (1):CD003748. PubMed ID: 18254032
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol for peripheral arterial disease.
Robless P; Mikhailidis DP; Stansby GP
Cochrane Database Syst Rev; 2007 Jan; (1):CD003748. PubMed ID: 17253494
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline for intermittent claudication.
Salhiyyah K; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
Cochrane Database Syst Rev; 2012 Jan; 1():CD005262. PubMed ID: 22258961
[TBL] [Abstract][Full Text] [Related]
12. Endovascular revascularisation versus conservative management for intermittent claudication.
Fakhry F; Fokkenrood HJ; Spronk S; Teijink JA; Rouwet EV; Hunink MGM
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010512. PubMed ID: 29518253
[TBL] [Abstract][Full Text] [Related]
13. Prostanoids for intermittent claudication.
Robertson L; Andras A
Cochrane Database Syst Rev; 2013 Apr; (4):CD000986. PubMed ID: 23633305
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline for intermittent claudication.
Salhiyyah K; Forster R; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
Cochrane Database Syst Rev; 2015 Sep; 9(9):CD005262. PubMed ID: 26417854
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
Roset PN
Br J Surg; 2013 Dec; 100(13):1838. PubMed ID: 24227374
[No Abstract] [Full Text] [Related]
16. Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
Br J Surg; 2013 Dec; 100(13):1838-9. PubMed ID: 24227373
[No Abstract] [Full Text] [Related]
17. Naftidrofuryl for intermittent claudication.
De Backer TL; Vander Stichele R; Lehert P; Van Bortel L
Cochrane Database Syst Rev; 2008 Apr; (2):CD001368. PubMed ID: 18425872
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of cilostazol and other therapies for intermittent claudication.
Dawson DL
Am J Cardiol; 2001 Jun; 87(12A):19D-27D. PubMed ID: 11434896
[TBL] [Abstract][Full Text] [Related]
19. Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication.
Smith JA
Clin Cardiol; 2002 Mar; 25(3):91-4. PubMed ID: 11892686
[TBL] [Abstract][Full Text] [Related]
20. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
